Epidemiology and clinical presentation of Panton-Valentine leukocidin positive methicillin-resistant Staphylococcus aureus;Epidemiología y forma de presentación clínica de las infecciones originadas por Staphylococcus aureus resistente a meticilina productor de leucocidina de Panton-Valentine

Revista Espanola de Quimioterapia

Volumn 23, Issue 2, 2010, Pages 93-99

  Cobos Trigueros, Nazaret ^a   Pitart, Cristina ^a   Marco, Francesc ^a   Martínez, Jose A ^a   Almela, Manel ^a   López, Josefina ^a   Ortega, Mar ^a   Soriano, Alex ^a   Mensa, José ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Acess; Community acquired; Methicillin resistant; Panton Valentine leukocidin; Sin and soft tissue infection; Staphylococcus aureus

Indexed keywords

COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MALE; METASTASIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; POLYMERASE CHAIN REACTION; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TOXINS; EXOTOXINS; FEMALE; HIV SEROPOSITIVITY; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFT TISSUE INFECTIONS; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; YOUNG ADULT;

EID: 77956476660     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009;64:441-446.
2. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130-1133. (Pubitemid 46328024)
3. Villaruz AE, Wardenburg JB, Khan BA, Whitney AR, Sturdevant DE, Gardner DJ et al. A Point Mutation in the agr Locus rather than Expression of the Panton-Valentine Leukocidin Caused Previously Reported Phenotypes in Staphylococcus aureus Pneumonia and Gene Regulation. J Infect Dis 2009;200:724-734.
4. Rodriguez-Bano J, Angeles DM, Blas MA, Borraz C, Pau GM, Almirante B et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain. Clin Microbiol Infect 2009;15:1111-1116.
5. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674.
6. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. Methicillin-Resistant Staphylococcus aureus Disease in Three Communities. N Engl J Med 2005;352:1436-1444.
7. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-1453.
8. Morgan MS. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 2007;30:289-296.
9. Larsen AR, Bocher S, Stegger M, Goering R, Pallesen LV, Skov R. Epidemiology of European community-associated methicillinresistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004. J Clin Microbiol 2008;46:62-68.
10. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007;60:1258-1263.
11. Manzur A, Dominguez AM, Pujol M, Gonzalez MP, Limon E, Hornero A et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008;14:377-380.
12. Cercenado E, Cuevas O, Marin M, Bouza E, Trincado P, Boquete T et al. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates. Diagn Microbiol Infect Dis 2008;61:143-149.
13. Broseta A, Chaves F, Rojo P, Otero JR. Emergence of a single clone of community-associated methicillin-resistant Staphylococcus aureus in southern Madrid children. Enferm Infecc Microbiol Clin 2006;24:31-35.
14. Daskalaki M, Rojo P, Marin-Ferrer M, Barrios M, Otero JR, Chaves F. Panton-Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clin Microbiol Infect 2009;16:74-77.
15. Ramos A, Ley L, Munez E, Videl A, Sanchez I. Brain Abscess due to Panton-Valentine Leukocidin-Positive Staphylococcus aureus. Infection 2008;37:365-367.
16. Aspiroz C, Martin I, Lozano C, Torres C. First case in Spain of meningitis caused by community-acquired methicillin-resistant Staphylococcus aureus ST88 producing Panton-Valentine leucocidin. Enferm Infecc Microbiol Clin 2010;28:70-71.
17. Ruiz de GE, Oliver A, Herrero J, Perez JL. Nosocomial pneumonia due to community-acquired, methicillin-resistant, Panton-Valentine-leukocidin-producing Staphylococcus aureus. Enferm Infecc Microbiol Clin 2008;26:533-534.
18. Onso-Tarres C, Villegas ML, de Gispert FJ, Cortes-Lletget MC, Rovira PA, Etienne J. Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness. Eur J Clin Microbiol Infect Dis 2005;24:756-759.
19. Cercenado E, Ruiz de GE. [Community-acquired methicillin-resistant Staphylococcus aureus]. Enferm Infecc Microbiol Clin 2008;26 Suppl 13:19-24.
20. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillinresistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006;144:309-317.
21. Goering RV, McDougal LK, Fosheim GE, Bonnstetter KK, Wolter DJ, Tenover FC. Epidemiologic Distribution of the Arginine Catabolic Mobile Element among Selected Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates. J Clin Microbiol 2007;45:1981-1984.
22. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731-739.
23. Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008;197:1523-1530.
24. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 2007;18:521-526.
25. Lee NE, Taylor MM, Bancroft E, Ruane PJ, Morgan M, McCoy L et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40:1529-1534.
26. Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL et al. Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men. Ann Intern Med 2008;148:249-257.
27. Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D et al. Epidemiology and Outcomes of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection. J Clin Microbiol 2007;45:1705-1711.
28. Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 2008;49:231-233.
29. Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N, Bharadwa K et al. Clinical and Epidemiologic Characteristics Cannot Distinguish Community-Associated Methicillin-Resistant Staphylococcus aureus Infection from Methicillin-Susceptible S. aureus Infection: A Prospective Investigation. Clin Infect Dis 2007;44:471-482.
30. Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Remington F, Ro P et al. Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection. Antimicrob Agents Chemother 2007;51:4044-4048.
31. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007;44:777-784.
32. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008;46:799-806.
33. Kahl BC, Peters G. Microbiology. Mayhem in the lung. Science 2007;315:1082-1083.
34. Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe CA-MRSA pneumonia. Eur Respir J 2009;34:1148-58.
35. Hidron AI, Low CE, Honig EG, Blumberg HM. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009;9:384-392.
36. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-759.
37. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124:1789-1797.
38. Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46:193-200. (Pubitemid 351269157)